These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 18307537)

  • 1. The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells.
    Guay D; Garand C; Reddy S; Schmutte C; Lebel M
    Cancer Sci; 2008 Apr; 99(4):762-9. PubMed ID: 18307537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Förster Resonance Energy Transfer Based Biosensor for Targeting the hNTH1-YB1 Interface as a Potential Anticancer Drug Target.
    Senarisoy M; Barette C; Lacroix F; De Bonis S; Stelter M; Hans F; Kleman JP; Fauvarque MO; Timmins J
    ACS Chem Biol; 2020 Apr; 15(4):990-1003. PubMed ID: 32125823
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stimulation of human endonuclease III by Y box-binding protein 1 (DNA-binding protein B). Interaction between a base excision repair enzyme and a transcription factor.
    Marenstein DR; Ocampo MT; Chan MK; Altamirano A; Basu AK; Boorstein RJ; Cunningham RP; Teebor GW
    J Biol Chem; 2001 Jun; 276(24):21242-9. PubMed ID: 11287425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substrate specificity of human endonuclease III (hNTH1). Effect of human APE1 on hNTH1 activity.
    Marenstein DR; Chan MK; Altamirano A; Basu AK; Boorstein RJ; Cunningham RP; Teebor GW
    J Biol Chem; 2003 Mar; 278(11):9005-12. PubMed ID: 12519758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light.
    Ohga T; Koike K; Ono M; Makino Y; Itagaki Y; Tanimoto M; Kuwano M; Kohno K
    Cancer Res; 1996 Sep; 56(18):4224-8. PubMed ID: 8797596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo dimerization of human endonuclease III stimulates its activity.
    Liu X; Choudhury S; Roy R
    J Biol Chem; 2003 Dec; 278(50):50061-9. PubMed ID: 14522981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An integrative approach to identify YB-1-interacting proteins required for cisplatin resistance in MCF7 and MDA-MB-231 breast cancer cells.
    Garand C; Guay D; Sereduk C; Chow D; Tsofack SP; Langlois M; Perreault E; Yin HH; Lebel M
    Cancer Sci; 2011 Jul; 102(7):1410-7. PubMed ID: 21466612
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Twist promotes tumor cell growth through YB-1 expression.
    Shiota M; Izumi H; Onitsuka T; Miyamoto N; Kashiwagi E; Kidani A; Yokomizo A; Naito S; Kohno K
    Cancer Res; 2008 Jan; 68(1):98-105. PubMed ID: 18172301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted disruption of one allele of the Y-box binding protein-1 (YB-1) gene in mouse embryonic stem cells and increased sensitivity to cisplatin and mitomycin C.
    Shibahara K; Uchiumi T; Fukuda T; Kura S; Tominaga Y; Maehara Y; Kohno K; Nakabeppu Y; Tsuzuki T; Kuwano M
    Cancer Sci; 2004 Apr; 95(4):348-53. PubMed ID: 15072594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NONO and RALY proteins are required for YB-1 oxaliplatin induced resistance in colon adenocarcinoma cell lines.
    Tsofack SP; Garand C; Sereduk C; Chow D; Aziz M; Guay D; Yin HH; Lebel M
    Mol Cancer; 2011 Nov; 10():145. PubMed ID: 22118625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Y-box binding protein 1 enhances DNA topoisomerase 1 activity and sensitivity to camptothecin via direct interaction.
    Wu Y; Wang KY; Li Z; Liu YP; Izumi H; Uramoto H; Nakayama Y; Ito K; Kohno K
    J Exp Clin Cancer Res; 2014 Dec; 33(1):112. PubMed ID: 25539742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncation of amino-terminal tail stimulates activity of human endonuclease III (hNTH1).
    Liu X; Roy R
    J Mol Biol; 2002 Aug; 321(2):265-76. PubMed ID: 12144783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.
    Guay D; Evoy AA; Paquet E; Garand C; Bachvarova M; Bachvarov D; Lebel M
    Int J Biochem Cell Biol; 2008; 40(11):2492-507. PubMed ID: 18571458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Base excision repair by hNTH1 and hOGG1: a two edged sword in the processing of DNA damage in gamma-irradiated human cells.
    Yang N; Chaudhry MA; Wallace SS
    DNA Repair (Amst); 2006 Jan; 5(1):43-51. PubMed ID: 16111924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene.
    Ohga T; Uchiumi T; Makino Y; Koike K; Wada M; Kuwano M; Kohno K
    J Biol Chem; 1998 Mar; 273(11):5997-6000. PubMed ID: 9497311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. YB-1 promotes strand separation in vitro of duplex DNA containing either mispaired bases or cisplatin modifications, exhibits endonucleolytic activities and binds several DNA repair proteins.
    Gaudreault I; Guay D; Lebel M
    Nucleic Acids Res; 2004; 32(1):316-27. PubMed ID: 14718551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential specificity of human and Escherichia coli endonuclease III and VIII homologues for oxidative base lesions.
    Katafuchi A; Nakano T; Masaoka A; Terato H; Iwai S; Hanaoka F; Ide H
    J Biol Chem; 2004 Apr; 279(14):14464-71. PubMed ID: 14734554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Suppresses lung resistance-related protein expression through Y-box binding protein 1 in the MCF-7 breast tumor cell line.
    Tian B; Liu J; Liu B; Dong Y; Liu J; Song Y; Sun Z
    J Cell Physiol; 2011 Dec; 226(12):3433-41. PubMed ID: 21344396
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased nuclear localization of transcription factor YB-1 in acquired cisplatin-resistant ovarian cancer.
    Yahata H; Kobayashi H; Kamura T; Amada S; Hirakawa T; Kohno K; Kuwano M; Nakano H
    J Cancer Res Clin Oncol; 2002 Nov; 128(11):621-6. PubMed ID: 12458343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Y-box binding protein 1 is up-regulated in proliferative breast cancer and its inhibition deregulates the cell cycle.
    Yu YN; Yip GW; Tan PH; Thike AA; Matsumoto K; Tsujimoto M; Bay BH
    Int J Oncol; 2010 Aug; 37(2):483-92. PubMed ID: 20596676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.